Výsledky vyhledávání - "Marlyane Motta"

Akademický článek

709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

Externí odkaz: https://doaj.org/article/8f9a46acdb034c0983a0a3eed0d03d8c

Zobrazit plný text záznamu

Akademický článek

801 PRIME™ IL-15 (RPTR-147): Preliminary clinical results and biomarker analysis from a first-in-human Phase 1 study of IL-15 loaded peripherally-derived autologous T cell therapy in solid tumor patients

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

Externí odkaz: https://doaj.org/article/07672bb2787a4617959a7393354d006a

Zobrazit plný text záznamu

Pub fees email yes from A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Autor: Susan N. Chi, Sudha Parasuraman, Jason R. Dobson, Suraj G. Bhansali, Alessandro Matano, Marlyane Motta, Giles W. Robinson, Thomas Cash, Shakeel Modak, Andrew D.J. Pearson, Aurélien Marabelle, Nicholas G. Gottardo, James I. Geller, Matthias Fischer, Steven G. DuBois, Franck Bourdeaut, Birgit Geoerger

Pub fees email yes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d51f0ad014a0e5d759351e185cfaf4
https://doi.org/10.1158/1078-0432.22467020.v1

Zobrazit plný text záznamu

Data from A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Purpose: The cyclin-dependent kinase (CDK) 4/6 inhibitor, ribociclib (LEE011), displayed preclinical activity in neuroblastoma and malignant rhabdoid tumor (MRT) models. In this phase I study, the maximum tolerated dose (MTD) and recommended phase II

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2359541c8e3bbb2c562e64b052e11990
https://doi.org/10.1158/1078-0432.c.6526511.v1

Zobrazit plný text záznamu

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

Background RPTR-147 is a novel autologous non-genetically modified multi-clonal T cell product loaded with an IL15-Fc nanogel. The product was derived from rare peripherally-derived anti-tumor T cell clones that were primed against a multi-antigen ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2478c980240cf16d3393e3f460357193
https://doaj.org/article/07672bb2787a4617959a7393354d006a

Zobrazit plný text záznamu

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Autor: James I. Geller, Andrew D.J. Pearson, Shakeel Modak, Sudha Parasuraman, Franck Bourdeaut, Jason R. Dobson, Steven G. DuBois, Susan N. Chi, Thomas Cash, Giles W. Robinson, Matthias Fischer, Marlyane Motta, Suraj G. Bhansali, Alessandro Matano, Birgit Geoerger, Nicholas G. Gottardo, Aurélien Marabelle

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 23(10)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd8d5af489ec61431b3b88eac22cf65
https://pubmed.ncbi.nlm.nih.gov/28432176

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání